{"entity":{"type":"insider","cik":"0001780649","url":"/insider/0001780649","json_url":"/insider/0001780649.json","name":"ROBINS CHAD M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":160,"n_filings":38,"first":"2020-01-29","last":"2026-08-19","span_basis":"filed_date"},"name_variants":[{"name":"ROBINS CHAD M","source":"filing","n_filings":38,"first_seen":"2020-01-29","last_seen":"2026-08-19"}],"transactions":[{"id":9298911,"accession":"0001780649-26-000014","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001780649-26-000014","line_url":"/filing/0001780649-26-000014#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":204.0,"shares_display":"204","price_per_share":25.14,"price_display":"25.14","price_state":"stated","total_value":5128.56,"total_display":"5,128.56","shares_owned_after":2180518.0,"shares_owned_after_display":"2,180,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"insider"},{"id":9298910,"accession":"0001780649-26-000014","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001780649-26-000014","line_url":"/filing/0001780649-26-000014#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":278472.0,"shares_display":"278,472","price_per_share":24.48,"price_display":"24.48","price_state":"stated","total_value":6816994.56,"total_display":"6,816,994.56","shares_owned_after":2180722.0,"shares_owned_after_display":"2,180,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"insider"},{"id":9298909,"accession":"0001780649-26-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780649-26-000014","line_url":"/filing/0001780649-26-000014#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2525.0,"shares_display":"2,525","price_per_share":25.57,"price_display":"25.57","price_state":"stated","total_value":64564.25,"total_display":"64,564.25","shares_owned_after":2180518.0,"shares_owned_after_display":"2,180,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"insider"},{"id":9298908,"accession":"0001780649-26-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780649-26-000014","line_url":"/filing/0001780649-26-000014#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318799.0,"shares_display":"318,799","price_per_share":25.08,"price_display":"25.08","price_state":"stated","total_value":7995478.92,"total_display":"7,995,478.92","shares_owned_after":2183043.0,"shares_owned_after_display":"2,183,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"insider"},{"id":6176279,"accession":"0001780649-26-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780649-26-000011","line_url":"/filing/0001780649-26-000011#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37263.0,"shares_display":"37,263","price_per_share":15.19,"price_display":"15.19","price_state":"stated","total_value":566024.97,"total_display":"566,024.97","shares_owned_after":2180518.0,"shares_owned_after_display":"2,180,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-08","scope":"insider"},{"id":6176274,"accession":"0001780649-26-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780649-26-000011","line_url":"/filing/0001780649-26-000011#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83332.0,"shares_display":"83,332","price_per_share":14.41,"price_display":"14.41","price_state":"stated","total_value":1200814.12,"total_display":"1,200,814.12","shares_owned_after":2217781.0,"shares_owned_after_display":"2,217,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-08","scope":"insider"},{"id":5865282,"accession":"0001780649-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780649-26-000007","line_url":"/filing/0001780649-26-000007#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":329600.0,"shares_display":"329,600","price_per_share":13.17,"price_display":"13.17","price_state":"stated","total_value":4340832.0,"total_display":"4,340,832.00","shares_owned_after":2301113.0,"shares_owned_after_display":"2,301,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-13","scope":"insider"},{"id":5865280,"accession":"0001780649-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780649-26-000007","line_url":"/filing/0001780649-26-000007#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140567.0,"shares_display":"140,567","price_per_share":13.17,"price_display":"13.17","price_state":"stated","total_value":1851267.39,"total_display":"1,851,267.39","shares_owned_after":2630713.0,"shares_owned_after_display":"2,630,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-13","scope":"insider"},{"id":5989495,"accession":"0001780649-26-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001780649-26-000003","line_url":"/filing/0001780649-26-000003#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50703.0,"shares_display":"50,703","price_per_share":15.49,"price_display":"15.49","price_state":"stated","total_value":785389.47,"total_display":"785,389.47","shares_owned_after":1936627.0,"shares_owned_after_display":"1,936,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-03","scope":"insider"},{"id":5989492,"accession":"0001780649-26-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001780649-26-000003","line_url":"/filing/0001780649-26-000003#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2380.0,"shares_display":"2,380","price_per_share":16.15,"price_display":"16.15","price_state":"stated","total_value":38437.0,"total_display":"38,437.00","shares_owned_after":1934247.0,"shares_owned_after_display":"1,934,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-03","scope":"insider"},{"id":5989487,"accession":"0001780649-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780649-26-000003","line_url":"/filing/0001780649-26-000003#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":289024.0,"shares_display":"289,024","price_per_share":15.82,"price_display":"15.82","price_state":"stated","total_value":4572359.68,"total_display":"4,572,359.68","shares_owned_after":1987330.0,"shares_owned_after_display":"1,987,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":5989484,"accession":"0001780649-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780649-26-000003","line_url":"/filing/0001780649-26-000003#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":182891.0,"shares_display":"182,891","price_per_share":15.99,"price_display":"15.99","price_state":"stated","total_value":2924427.09,"total_display":"2,924,427.09","shares_owned_after":2276354.0,"shares_owned_after_display":"2,276,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-03","scope":"insider"},{"id":5935610,"accession":"0001780649-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780649-26-000002","line_url":"/filing/0001780649-26-000002#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124998.0,"shares_display":"124,998","price_per_share":18.44,"price_display":"18.44","price_state":"stated","total_value":2304963.12,"total_display":"2,304,963.12","shares_owned_after":2459245.0,"shares_owned_after_display":"2,459,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":5911382,"accession":"0001780649-26-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780649-26-000001","line_url":"/filing/0001780649-26-000001#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124998.0,"shares_display":"124,998","price_per_share":15.59,"price_display":"15.59","price_state":"stated","total_value":1948718.82,"total_display":"1,948,718.82","shares_owned_after":2584243.0,"shares_owned_after_display":"2,584,243","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":4322372,"accession":"0001780649-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780649-25-000003","line_url":"/filing/0001780649-25-000003#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124998.0,"shares_display":"124,998","price_per_share":18.94,"price_display":"18.94","price_state":"stated","total_value":2367462.12,"total_display":"2,367,462.12","shares_owned_after":2709241.0,"shares_owned_after_display":"2,709,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-01","scope":"insider"},{"id":4322368,"accession":"0001780649-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780649-25-000003","line_url":"/filing/0001780649-25-000003#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35736.0,"shares_display":"35,736","price_per_share":19.68,"price_display":"19.68","price_state":"stated","total_value":703284.48,"total_display":"703,284.48","shares_owned_after":2834239.0,"shares_owned_after_display":"2,834,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-26","filed_date":"2025-12-01","scope":"insider"},{"id":4777853,"accession":"0001780649-25-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001780649-25-000002","line_url":"/filing/0001780649-25-000002#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1867.0,"shares_display":"1,867","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":28005.0,"total_display":"28,005.00","shares_owned_after":2869975.0,"shares_owned_after_display":"2,869,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-12","scope":"insider"},{"id":4777851,"accession":"0001780649-25-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780649-25-000002","line_url":"/filing/0001780649-25-000002#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1237.0,"shares_display":"1,237","price_per_share":14.57,"price_display":"14.57","price_state":"stated","total_value":18023.09,"total_display":"18,023.09","shares_owned_after":2871851.0,"shares_owned_after_display":"2,871,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-11","filed_date":"2025-11-12","scope":"insider"},{"id":4777847,"accession":"0001780649-25-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780649-25-000002","line_url":"/filing/0001780649-25-000002#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86161.0,"shares_display":"86,161","price_per_share":14.73,"price_display":"14.73","price_state":"stated","total_value":1269151.53,"total_display":"1,269,151.53","shares_owned_after":2873088.0,"shares_owned_after_display":"2,873,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider"},{"id":4464651,"accession":"0001062993-25-004809","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-25-004809","line_url":"/filing/0001062993-25-004809#line-5","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102218.0,"shares_display":"102,218","price_per_share":7.64,"price_display":"7.64","price_state":"stated","total_value":780945.52,"total_display":"780,945.52","shares_owned_after":2959249.0,"shares_owned_after_display":"2,959,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-06","scope":"insider"},{"id":4464649,"accession":"0001062993-25-004809","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-25-004809","line_url":"/filing/0001062993-25-004809#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81206.0,"shares_display":"81,206","price_per_share":6.98,"price_display":"6.98","price_state":"stated","total_value":566817.88,"total_display":"566,817.88","shares_owned_after":2850495.0,"shares_owned_after_display":"2,850,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider"},{"id":4464645,"accession":"0001062993-25-004809","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-25-004809","line_url":"/filing/0001062993-25-004809#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36145.0,"shares_display":"36,145","price_per_share":6.99,"price_display":"6.99","price_state":"stated","total_value":252653.55,"total_display":"252,653.55","shares_owned_after":2814350.0,"shares_owned_after_display":"2,814,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider"},{"id":4663996,"accession":"0001062993-25-003241","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-25-003241","line_url":"/filing/0001062993-25-003241#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99107.0,"shares_display":"99,107","price_per_share":8.44,"price_display":"8.44","price_state":"stated","total_value":836463.08,"total_display":"836,463.08","shares_owned_after":2576701.0,"shares_owned_after_display":"2,576,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-21","scope":"insider"},{"id":4663990,"accession":"0001062993-25-003241","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-003241","line_url":"/filing/0001062993-25-003241#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":186080.0,"shares_display":"186,080","price_per_share":8.46,"price_display":"8.46","price_state":"stated","total_value":1574236.8,"total_display":"1,574,236.80","shares_owned_after":2576701.0,"shares_owned_after_display":"2,576,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":4325627,"accession":"0001062993-25-002744","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-25-002744","line_url":"/filing/0001062993-25-002744#line-6","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":211160.0,"shares_display":"211,160","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":1794860.0,"total_display":"1,794,860.00","shares_owned_after":2576701.0,"shares_owned_after_display":"2,576,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-18","scope":"insider"},{"id":4325620,"accession":"0001062993-25-002744","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-25-002744","line_url":"/filing/0001062993-25-002744#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":158921.0,"shares_display":"158,921","price_per_share":8.46,"price_display":"8.46","price_state":"stated","total_value":1344471.66,"total_display":"1,344,471.66","shares_owned_after":2576701.0,"shares_owned_after_display":"2,576,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-18","scope":"insider"},{"id":4325612,"accession":"0001062993-25-002744","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-002744","line_url":"/filing/0001062993-25-002744#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100287.0,"shares_display":"100,287","price_per_share":8.44,"price_display":"8.44","price_state":"stated","total_value":846422.28,"total_display":"846,422.28","shares_owned_after":2576701.0,"shares_owned_after_display":"2,576,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-18","scope":"insider"},{"id":2597631,"accession":"0001062993-24-005758","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-24-005758","line_url":"/filing/0001062993-24-005758#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42794.0,"shares_display":"42,794","price_per_share":3.43,"price_display":"3.43","price_state":"stated","total_value":146783.42,"total_display":"146,783.42","shares_owned_after":2576701.0,"shares_owned_after_display":"2,576,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":2597626,"accession":"0001062993-24-005758","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-24-005758","line_url":"/filing/0001062993-24-005758#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5879.0,"shares_display":"5,879","price_per_share":3.44,"price_display":"3.44","price_state":"stated","total_value":20223.76,"total_display":"20,223.76","shares_owned_after":2619495.0,"shares_owned_after_display":"2,619,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":6295387,"accession":"0001209191-22-017696","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-22-017696","line_url":"/filing/0001209191-22-017696#line-7","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14815.0,"shares_display":"14,815","price_per_share":12.46,"price_display":"12.46","price_state":"stated","total_value":184594.9,"total_display":"184,594.90","shares_owned_after":1916154.0,"shares_owned_after_display":"1,916,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-09","filed_date":"2022-03-09","scope":"insider"},{"id":6295384,"accession":"0001209191-22-017696","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-017696","line_url":"/filing/0001209191-22-017696#line-5","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14815.0,"shares_display":"14,815","price_per_share":11.38,"price_display":"11.38","price_state":"stated","total_value":168594.7,"total_display":"168,594.70","shares_owned_after":1916154.0,"shares_owned_after_display":"1,916,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-08","filed_date":"2022-03-09","scope":"insider"},{"id":6295379,"accession":"0001209191-22-017696","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-017696","line_url":"/filing/0001209191-22-017696#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14315.0,"shares_display":"14,315","price_per_share":11.53,"price_display":"11.53","price_state":"stated","total_value":165051.95,"total_display":"165,051.95","shares_owned_after":1916154.0,"shares_owned_after_display":"1,916,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-09","scope":"insider"},{"id":6295377,"accession":"0001209191-22-017696","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-017696","line_url":"/filing/0001209191-22-017696#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":12.22,"price_display":"12.22","price_state":"stated","total_value":6110.0,"total_display":"6,110.00","shares_owned_after":1930469.0,"shares_owned_after_display":"1,930,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-09","scope":"insider"},{"id":6178845,"accession":"0001209191-22-017393","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-017393","line_url":"/filing/0001209191-22-017393#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4424.0,"shares_display":"4,424","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":53132.24,"total_display":"53,132.24","shares_owned_after":1916154.0,"shares_owned_after_display":"1,916,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":4955895,"accession":"0001209191-21-055586","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-055586","line_url":"/filing/0001209191-21-055586#line-5","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4902.0,"shares_display":"4,902","price_per_share":38.37,"price_display":"38.37","price_state":"stated","total_value":188089.74,"total_display":"188,089.74","shares_owned_after":1673559.0,"shares_owned_after_display":"1,673,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-10","scope":"insider"},{"id":4955889,"accession":"0001209191-21-055586","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-055586","line_url":"/filing/0001209191-21-055586#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98.0,"shares_display":"98","price_per_share":39.09,"price_display":"39.09","price_state":"stated","total_value":3830.82,"total_display":"3,830.82","shares_owned_after":1673461.0,"shares_owned_after_display":"1,673,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-10","scope":"insider"},{"id":4955885,"accession":"0001209191-21-055586","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-055586","line_url":"/filing/0001209191-21-055586#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24753.0,"shares_display":"24,753","price_per_share":38.42,"price_display":"38.42","price_state":"stated","total_value":951010.26,"total_display":"951,010.26","shares_owned_after":1678461.0,"shares_owned_after_display":"1,678,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-09","filed_date":"2021-09-10","scope":"insider"},{"id":4955881,"accession":"0001209191-21-055586","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-055586","line_url":"/filing/0001209191-21-055586#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11742.0,"shares_display":"11,742","price_per_share":38.34,"price_display":"38.34","price_state":"stated","total_value":450188.28,"total_display":"450,188.28","shares_owned_after":1705218.0,"shares_owned_after_display":"1,705,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-08","filed_date":"2021-09-10","scope":"insider"},{"id":4955875,"accession":"0001209191-21-055586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-055586","line_url":"/filing/0001209191-21-055586#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2004.0,"shares_display":"2,004","price_per_share":39.11,"price_display":"39.11","price_state":"stated","total_value":78376.44,"total_display":"78,376.44","shares_owned_after":1703214.0,"shares_owned_after_display":"1,703,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-08","filed_date":"2021-09-10","scope":"insider"},{"id":5293299,"accession":"0001209191-21-046710","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-046710","line_url":"/filing/0001209191-21-046710#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1501.0,"shares_display":"1,501","price_per_share":38.24,"price_display":"38.24","price_state":"stated","total_value":57398.24,"total_display":"57,398.24","shares_owned_after":1716960.0,"shares_owned_after_display":"1,716,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-12","filed_date":"2021-07-14","scope":"insider"},{"id":5476921,"accession":"0001209191-21-041790","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-041790","line_url":"/filing/0001209191-21-041790#line-5","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4255.0,"shares_display":"4,255","price_per_share":39.76,"price_display":"39.76","price_state":"stated","total_value":169178.8,"total_display":"169,178.80","shares_owned_after":1718461.0,"shares_owned_after_display":"1,718,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-17","scope":"insider"},{"id":5476918,"accession":"0001209191-21-041790","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-041790","line_url":"/filing/0001209191-21-041790#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":38.55,"price_display":"38.55","price_state":"stated","total_value":38550.0,"total_display":"38,550.00","shares_owned_after":1722716.0,"shares_owned_after_display":"1,722,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-17","scope":"insider"},{"id":5476916,"accession":"0001209191-21-041790","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-041790","line_url":"/filing/0001209191-21-041790#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4745.0,"shares_display":"4,745","price_per_share":38.13,"price_display":"38.13","price_state":"stated","total_value":180926.85,"total_display":"180,926.85","shares_owned_after":1723716.0,"shares_owned_after_display":"1,723,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-17","scope":"insider"},{"id":5476914,"accession":"0001209191-21-041790","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-041790","line_url":"/filing/0001209191-21-041790#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19100.0,"shares_display":"19,100","price_per_share":38.22,"price_display":"38.22","price_state":"stated","total_value":730002.0,"total_display":"730,002.00","shares_owned_after":1729361.0,"shares_owned_after_display":"1,729,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-17","scope":"insider"},{"id":5476912,"accession":"0001209191-21-041790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-041790","line_url":"/filing/0001209191-21-041790#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":39.23,"price_display":"39.23","price_state":"stated","total_value":35307.0,"total_display":"35,307.00","shares_owned_after":1728461.0,"shares_owned_after_display":"1,728,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-17","scope":"insider"},{"id":4985613,"accession":"0001209191-21-026181","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-21-026181","line_url":"/filing/0001209191-21-026181#line-8","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2943.0,"shares_display":"2,943","price_per_share":42.04,"price_display":"42.04","price_state":"stated","total_value":123723.72,"total_display":"123,723.72","shares_owned_after":1750518.0,"shares_owned_after_display":"1,750,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-08","filed_date":"2021-04-08","scope":"insider"},{"id":4985610,"accession":"0001209191-21-026181","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-026181","line_url":"/filing/0001209191-21-026181#line-7","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1957.0,"shares_display":"1,957","price_per_share":43.0,"price_display":"43.00","price_state":"stated","total_value":84151.0,"total_display":"84,151.00","shares_owned_after":1748561.0,"shares_owned_after_display":"1,748,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-08","filed_date":"2021-04-08","scope":"insider"},{"id":4985600,"accession":"0001209191-21-026181","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-026181","line_url":"/filing/0001209191-21-026181#line-6","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":43.78,"price_display":"43.78","price_state":"stated","total_value":4378.0,"total_display":"4,378.00","shares_owned_after":1748461.0,"shares_owned_after_display":"1,748,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-08","filed_date":"2021-04-08","scope":"insider"},{"id":4985593,"accession":"0001209191-21-026181","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-026181","line_url":"/filing/0001209191-21-026181#line-5","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":40.61,"price_display":"40.61","price_state":"stated","total_value":158379.0,"total_display":"158,379.00","shares_owned_after":1754561.0,"shares_owned_after_display":"1,754,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-07","filed_date":"2021-04-08","scope":"insider"},{"id":4985590,"accession":"0001209191-21-026181","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-026181","line_url":"/filing/0001209191-21-026181#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780649","owner_name":"ROBINS CHAD M","owner_url":"/insider/0001780649","role":"Director, Officer (CEO and Chairman)","officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":41.45,"price_display":"41.45","price_state":"stated","total_value":45595.0,"total_display":"45,595.00","shares_owned_after":1753461.0,"shares_owned_after_display":"1,753,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-07","filed_date":"2021-04-08","scope":"insider"}],"next_cursor":"2021-04-07|4985590","ledger_fault":false,"count":{"value":160,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":160,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":160},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001478320","name":"Adaptive Biotechnologies Corp","url":"/issuer/0001478320","role":"Director, Officer (CEO and Chairman)","n_filings":38,"first_seen":"2020-01-29","last_seen":"2026-08-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001780649","retrieved_at":"2026-08-21T15:32:29+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}